Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Breast Cancer

Free Subscription 04.08.2025 1 AJR Am J Roentgenol 2 Am J Clin Oncol 8 Ann Surg Oncol 6 BMC Cancer 1 Br J Cancer 3 Breast Cancer 3 Breast Cancer (Dove Med Press) 3 Breast Cancer Res 2 Breast Cancer Res Treat 3 Cancer Epidemiol Biomarkers Prev 1 Cancer Res 2 Clin Breast Cancer 1 Eur J Cancer 2 Eur J Surg Oncol 2 Int J Cancer 1 J Surg Oncol 1 Lancet Oncol 1 Mod Pathol 1 Nature 4 NPJ Breast Cancer 1 Oncogene 1 PLoS Genet 1 PLoS Med 5 PLoS One 2 Radiology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJR Am J Roentgenol

1. LIU B, Wu L, Liu C, Long X, et al
   Baseline and Early Treatment MRI Model for Predicting Complete Pathologic Response to Neoadjuvant Chemoimmunotherapy in Patients With Triple-Negative Breast Cancer.
   AJR Am J Roentgenol. 2025 Jul 30. doi: 10.2214/AJR.25.33178.
   PubMed         Abstract available
   
   

   
   Am J Clin Oncol

2. STEPHENS MJ, Kasliwal N, Burnette UJ, Onyewadume L, et al
   Impact of Chemotherapy on Financial Toxicity in African American Breast Cancer Patients: Early Findings From the Navigator-Assisted Hypofractionation Phase I Clinical Trial.
   Am J Clin Oncol. 2025 Jul 31. doi: 10.1097/COC.0000000000001241.
   PubMed         Abstract available
   
   
3. ONYEWADUME L, Burnette U, Flores LE, McClelland S 3rd, et al
   Navigator-Assisted Hypofractionation Program Survey Validation for African American Breast Cancer Patients.
   Am J Clin Oncol. 2025 Jul 31. doi: 10.1097/COC.0000000000001242.
   PubMed        
   
   

   
   Ann Surg Oncol

4. CHAN K, Yao K
   ASO Author Reflections: Leveraging Cancer Accreditation Standards to Improve the Delivery of Breast Cancer Care.
   Ann Surg Oncol. 2025 Jul 28. doi: 10.1245/s10434-025-17956.
   PubMed        
   
   
5. KERIVAN L, Wagner J, Nye L, Balanoff C, et al
   Surgical Choice among Women with a First Breast Cancer and Pathogenic Variants in Breast Cancer Genes.
   Ann Surg Oncol. 2025 Jul 27. doi: 10.1245/s10434-025-17859.
   PubMed         Abstract available
   
   
6. REASON EH, Thomas SM, Chanenchuk T, Botty van den Bruele AM, et al
   Neoadjuvant Chemotherapy is Not Associated with Improved Overall Survival in Metaplastic Breast Cancer Regardless of Tumor Subtype.
   Ann Surg Oncol. 2025 Jul 29. doi: 10.1245/s10434-025-17938.
   PubMed         Abstract available
   
   
7. VETTER CD, Hoskin T, Olson C, Giridhar K, et al
   Validation of the Performance of the Novel Prognostic Staging System for Overall Survival in De Novo Metastatic Breast Cancer and Demonstration of Performance for Cancer-Specific Outcomes.
   Ann Surg Oncol. 2025 Jul 29. doi: 10.1245/s10434-025-17863.
   PubMed         Abstract available
   
   
8. PRATT CG, McClelland PH, Long SA, Moore AN, et al
   The Metaplastic Conundrum: A National Cancer Database Analysis of Metaplastic versus Triple-Negative Ductal Breast Cancer.
   Ann Surg Oncol. 2025 Jul 29. doi: 10.1245/s10434-025-17932.
   PubMed         Abstract available
   
   
9. MARTIN G, Kensler KH, Tamimi RM, Bea VJ, et al
   ASO Author Reflections: Reconstructing Equity: Policy's Role in Post-Mastectomy Breast Cancer Care.
   Ann Surg Oncol. 2025 Jul 31. doi: 10.1245/s10434-025-17941.
   PubMed        
   
   
10. YAO J
    ASO Author Reflections: Prospective Validation of Lymphatic Contrast-Enhanced Ultrasound for Non-invasive Sentinel Lymph Node Assessment in Breast Cancer.
    Ann Surg Oncol. 2025 Jul 31. doi: 10.1245/s10434-025-17761.
    PubMed        
    
    
11. MALHOTRA S, Choi DX, Sevilimedu V, Greenup RA, et al
    Medicaid Expansion Is Associated with Lower Mortality in Patients with Locally Advanced Breast Cancer.
    Ann Surg Oncol. 2025 Jul 30. doi: 10.1245/s10434-025-17865.
    PubMed         Abstract available
    
    

    
    BMC Cancer

12. CHAI C, Shao K, Shan G, Li P, et al
    Dosimetric study of TrueBeam single-isocenter vs. Halcyon dual-isocenter VMAT radiotherapy plans for postoperative left-sided breast cancer.
    BMC Cancer. 2025;25:1214.
    PubMed         Abstract available
    
    
13. LUO L, Zhang X, Chen L, Chen Z, et al
    Dual-targeting and steric hindrance resolution in HER2 IHC: a novel approach to improve diagnostic sensitivity.
    BMC Cancer. 2025;25:1231.
    PubMed         Abstract available
    
    
14. WANG W, Wu B, Li J, Shang Y, et al
    The application and predictive value of the weight-adjusted-waist index in BC prevalence assessment: a comprehensive statistical and machine learning analysis using NHANES data.
    BMC Cancer. 2025;25:1234.
    PubMed         Abstract available
    
    
15. SHARIATMADARI H, Taheri-Kharameh Z, Kamaliuon N, Ghanbari Hashem Abadi BA, et al
    Comparing the effectiveness of gratitude intervention and behavioral activation technique in breast cancer patients: a randomized trial.
    BMC Cancer. 2025;25:1226.
    PubMed         Abstract available
    
    
16. SUN Q, Hu J, Ye Y, Ma L, et al
    The effect of smoking on breast cancer screening results in female population: a study in Wu wei, China.
    BMC Cancer. 2025;25:1225.
    PubMed         Abstract available
    
    
17. EKDAHL HJELM T, Gebremariam TY, Weldearegay MF, Sori M, et al
    Stage at diagnosis and tumor characteristics among young women and men with breast cancer, in Ethiopia and Sweden, a descriptive cross-sectional study.
    BMC Cancer. 2025;25:1222.
    PubMed         Abstract available
    
    

    
    Br J Cancer

18. HARVIE M, Pegington M, Howell A, Lim Y, et al
    Randomised phase-2 screening trial of intermittent energy restriction plus resistance exercise versus resistance exercise alone during chemotherapy for advanced breast cancer.
    Br J Cancer. 2025 Jul 31. doi: 10.1038/s41416-025-03129.
    PubMed         Abstract available
    
    

    
    Breast Cancer

19. KUBA S, Sagara Y, Yano H, Maeda S, et al
    A retrospective multi-center cohort study investigating safety of sentinel lymph node biopsy for axillary staging in clinical T3-4c breast cancer.
    Breast Cancer. 2025 Aug 1. doi: 10.1007/s12282-025-01749.
    PubMed         Abstract available
    
    
20. HAMAMOTO Y, Makita K, Nagasaki K, Kanzaki H, et al
    Internal mammary node failure in invasive breast cancer patients who received post-operative radiotherapy without prophylactic internal mammary node irradiation.
    Breast Cancer. 2025 Jul 30. doi: 10.1007/s12282-025-01746.
    PubMed         Abstract available
    
    
21. HOSHINO M, Shimoi T, Yamanaka T, Kitadai R, et al
    Baseline risk variability by eligibility criteria in Cohort 1 of the monarchE trial for high-risk HR-positive, HER2-negative breast cancer.
    Breast Cancer. 2025 Jul 28. doi: 10.1007/s12282-025-01747.
    PubMed         Abstract available
    
    

    
    Breast Cancer (Dove Med Press)

22. OBEAGU EI
    N2 Neutrophils and Tumor Progression in Breast Cancer: Molecular Pathways and Implications.
    Breast Cancer (Dove Med Press). 2025;17:639-651.
    PubMed         Abstract available
    
    
23. ZHANG J, Zhuang J, Chen X, Chu T, et al
    Effectiveness of a Care Plan Based on the Multi-Theory Model in Reducing Fear of Disease Progression and Improving Quality of Life in Breast Cancer Patients: A Randomized Controlled Trial.
    Breast Cancer (Dove Med Press). 2025;17:653-667.
    PubMed         Abstract available
    
    
24. SONG S, Sun L, Liu X, Zhang L, et al
    Clinical Prognosis and Nomograms for Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Patients Treated with Palbociclib and Endocrine Therapy.
    Breast Cancer (Dove Med Press). 2025;17:669-681.
    PubMed         Abstract available
    
    

    
    Breast Cancer Res

25. HERNANDEZ A, Puppala A, Hedlich-Dwyer J, Mukherjee N, et al
    Short-term consumption of the modified standard American diet perturbed the metabolic balance and altered DNA damage in MMTV-PyMT transgenic mice.
    Breast Cancer Res. 2025;27:138.
    PubMed         Abstract available
    
    
26. ZAFAR S, Badshah Y, Shabbir M, Mussarat U, et al
    Missense variants in PRKCD: elucidating their potential association with breast cancer.
    Breast Cancer Res. 2025;27:139.
    PubMed         Abstract available
    
    
27. LIU N, van der Velde JJS, Ramdjielal S, Koedoot E, et al
    Pharmacological CLK inhibition disrupts SR protein function and RNA splicing blocking cell growth and migration in TNBC.
    Breast Cancer Res. 2025;27:140.
    PubMed         Abstract available
    
    

    
    Breast Cancer Res Treat

28. KLEBANER D, Park N, Stone K, Riaz F, et al
    Impact of timing and breastfeeding on postpartum breast cancer diagnostic patterns and outcomes.
    Breast Cancer Res Treat. 2025 Jul 30. doi: 10.1007/s10549-025-07796.
    PubMed         Abstract available
    
    
29. GIUFFRE GM, Carbognin L, Masone Iacobucci G, Gistro M, et al
    Cognitive effects of aromatase inhibitors in early breast cancer patients: a prospective study.
    Breast Cancer Res Treat. 2025 Jul 29. doi: 10.1007/s10549-025-07788.
    PubMed         Abstract available
    
    

    
    Cancer Epidemiol Biomarkers Prev

30. CARROLL JE, Guard HE, March D, Arcaro KF, et al
    Urinary Levels of Endocrine-Disrupting Chemicals and Breast Density in Young Women.
    Cancer Epidemiol Biomarkers Prev. 2025;34:1306-1313.
    PubMed         Abstract available
    
    
31. YAGHJYAN L, Tamimi RM, Baker GM, Heng YJ, et al
    Associations of Stem Cell Markers with Lobular Involution in Benign Breast Tissue.
    Cancer Epidemiol Biomarkers Prev. 2025;34:1314-1321.
    PubMed         Abstract available
    
    
32. LOEHRER EA, van der Baan FH, Mooij TM, Andrieu N, et al
    Breast Density Changes after Risk-Reducing Salpingo-oophorectomy in Women with a Pathogenic Germline Variant in BRCA1 or BRCA2.
    Cancer Epidemiol Biomarkers Prev. 2025;34:1295-1305.
    PubMed         Abstract available
    
    

    
    Cancer Res

33. GONG H, Li Y, Yang W, Xie Z, et al
    PRODH2-Mediated Metabolism in the Bone Microenvironment Promotes Breast Cancer Metastasis.
    Cancer Res. 2025 Aug 1. doi: 10.1158/0008-5472.CAN-24-4391.
    PubMed         Abstract available
    
    

    
    Clin Breast Cancer

34. LIU S, Sun X, Liu N, Lin F, et al
    The Potential Role of Ubiquitin-Conjugating Enzyme E2C (UBE2C) in Breast Cancer Progression by Regulating the JNK Signaling Pathway.
    Clin Breast Cancer. 2025 Jul 4:S1526-8209(25)00186.
    PubMed         Abstract available
    
    
35. LEE KT, Geiss C, Fulton HJ, Charles D, et al
    Hidden Costs of Endocrine Therapy for Black Breast Cancer Survivors: A Qualitative Examination of Patient and Provider Experiences.
    Clin Breast Cancer. 2025 Jul 5:S1526-8209(25)00181.
    PubMed         Abstract available
    
    

    
    Eur J Cancer

36. GIORGI ROSSI P, Venturelli F
    Letter Re: Evaluation of screening mammography effectiveness: The IARC recommendations of 2015 need revision: Observational studies on breast cancer screening: different perspectives and questions require different approaches.
    Eur J Cancer. 2025;227:115659.
    PubMed        
    
    

    
    Eur J Surg Oncol

37. WOOLDRIK S, van de Voort EF, Struik G, Schouten BM, et al
    Cosmetic outcome and patient satisfaction following percutaneous thermal ablation of early-stage breast cancer; results of an open label randomized phase 2 trial.
    Eur J Surg Oncol. 2025;51:110305.
    PubMed         Abstract available
    
    
38. YU SWY, Ho CM, Kwok C, Soong I, et al
    Reply to: Comment on "Pre-operative radiotherapy for breast cancer patients receiving mastectomy and immediate autologous tissue reconstruction".
    Eur J Surg Oncol. 2025 Jul 17:110314. doi: 10.1016/j.ejso.2025.110314.
    PubMed        
    
    

    
    Int J Cancer

39. RASHID MU, Muhammad N, Arif S, Naeemi H, et al
    Genetic landscape of Pakistani familial breast cancer patients using multigene panel testing.
    Int J Cancer. 2025 Aug 1. doi: 10.1002/ijc.70070.
    PubMed         Abstract available
    
    
40. LIU W, Gupta S, Gupta S
    The role of UPR-related long noncoding RNAs in development of endocrine resistance in breast cancer.
    Int J Cancer. 2025 Aug 1. doi: 10.1002/ijc.70067.
    PubMed         Abstract available
    
    

    
    J Surg Oncol

41. WAREHAM C, Bertaux B, Chahine E, Homsy C, et al
    Geographical Presence of Plastic Surgeons in Relation to Breast Surgeons in the United States for Breast Reconstruction.
    J Surg Oncol. 2025;132:22-27.
    PubMed         Abstract available
    
    

    
    Lancet Oncol

42. GOURD E
    New test for breast cancer set to transform patient treatment.
    Lancet Oncol. 2025 Jul 24:S1470-2045(25)00461.
    PubMed        
    
    

    
    Mod Pathol

43. STEEN S, Boissin C, Rantalainen M, Acs B, et al
    Histological grade has clinical validity in neoadjuvant treated breast cancer: A multicenter study.
    Mod Pathol. 2025 Jul 25:100850. doi: 10.1016/j.modpat.2025.100850.
    PubMed         Abstract available
    
    

    
    Nature

44. CHIA SB, Johnson BJ, Hu J, Valenca-Pereira F, et al
    Respiratory viral infections awaken metastatic breast cancer cells in lungs.
    Nature. 2025 Jul 30. doi: 10.1038/s41586-025-09332.
    PubMed         Abstract available
    
    

    
    NPJ Breast Cancer

45. NOOR H, Zheng Y, Mantz AB, Zhou R, et al
    A 20-feature radiomic signature of triple-negative breast cancer identifies patients at high risk of death.
    NPJ Breast Cancer. 2025;11:79.
    PubMed         Abstract available
    
    
46. MIGLIACCIO I, Bonechi M, Romagnoli D, Boccalini G, et al
    Single-cell transcriptomics reveals biomarker heterogeneity linked to CDK4/6 Inhibitor resistance in breast cancer cell lines.
    NPJ Breast Cancer. 2025;11:82.
    PubMed         Abstract available
    
    
47. STEINBAUER S, Cowles JD, Sabbaghi MA, Poppelaars M, et al
    Enhanced bioluminescence imaging of tumor cells surviving chemotherapy in a murine model of triple-negative breast cancer.
    NPJ Breast Cancer. 2025;11:80.
    PubMed         Abstract available
    
    
48. PATEL P, Giordano A, Giordano S, Schlam I, et al
    Antibody-drug conjugates for treating early-stage breast cancer: current use, anticipated evolutions.
    NPJ Breast Cancer. 2025;11:81.
    PubMed         Abstract available
    
    

    
    Oncogene

49. GUO L, Rao Y, Song Y, Hu J, et al
    SIX1 transmits signals for breast cancer progression via the ZEB1/IL6/STAT3 signaling axis.
    Oncogene. 2025 Jul 26. doi: 10.1038/s41388-025-03499.
    PubMed         Abstract available
    
    

    
    PLoS Genet

50. GUPTA A, Huang L, Liu J, Chen K, et al
    Single-cell analysis of gene regulatory networks in the mammary glands of P4HA1-knockout mice.
    PLoS Genet. 2025;21:e1011505.
    PubMed         Abstract available
    
    

    
    PLoS Med

51. ZHANG J, Meng Y, Wang B, Wu X, et al
    Dalpiciclib combined with pyrotinib and endocrine therapy in women with ER-positive, HER2-positive advanced breast cancer: A prospective, multicenter, single-arm, phase 2 trial.
    PLoS Med. 2025;22:e1004669.
    PubMed         Abstract available
    
    

    
    PLoS One

52. BOGALE M, Mengstie TA, Tadesse E, Dejenie TA, et al
    Association of FGF Receptor-2rs2981578 SNP with breast cancer in women at the University of Gondar Comprehensive Specialized Hospital, Ethiopia.
    PLoS One. 2025;20:e0327034.
    PubMed         Abstract available
    
    
53. WATABE S, Watanabe T, Yada S, Aramaki E, et al
    Correction: Exploring a method for extracting concerns of multiple breast cancer patients in the domain of patient narratives using BERT and its optimization by domain adaptation using masked language modeling.
    PLoS One. 2025;20:e0329664.
    PubMed         Abstract available
    
    
54. LEE J, Foroughi M, Kung V, Ali R, et al
    Molecular and morphological alterations in breast tissue of transgender patients undergoing dihydrotestosterone therapy.
    PLoS One. 2025;20:e0325034.
    PubMed         Abstract available
    
    
55. LIU X, Wu H, Zhang S, Zhu Z, et al
    Higher red cell distribution width (RDW) is associated with increased all-cause and cardiovascular mortality in patients with breast cancer: A retrospective analysis of NHANES data (1999-2018).
    PLoS One. 2025;20:e0328680.
    PubMed         Abstract available
    
    
56. LI X, Liu Y, Wang Z, Bu X, et al
    Response Gene to Complement 32 promotes cell proliferation and tamoxifen resistance in breast cancer via elevated FoxM1 expression.
    PLoS One. 2025;20:e0328698.
    PubMed         Abstract available
    
    

    
    Radiology

57. LEE CI, Milch HS
    Clinically Meaningful AI Detection of Interval Breast Cancer at Digital Breast Tomosynthesis Screening.
    Radiology. 2025;316:e251860.
    PubMed        
    
    
58. BAHL M, Langarica S, Lamb LR, Kniss AS, et al
    AI to Reduce the Interval Cancer Rate of Screening Digital Breast Tomosynthesis.
    Radiology. 2025;316:e241050.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.